Puma Biotechnology
PBYI • NASDAQ
Puma Biotechnology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alan H. Auerbach, with a market cap of $369.4M.
Market Cap$369.4M
Employees185.0
CEOAlan H. Auerbach
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
PBY
Puma Biotechnology FAQ
Common questions about Puma Biotechnology
Puma Biotechnology is scheduled to report earnings for Q1 2026 on May 14, 2026 after market close. Analysts estimate revenue of $42.0M.
Puma Biotechnology has approximately 185 employees.